Stoke Therapeutics (STOK) Accumulated Depreciation & Amortization (2022 - 2024)
Historic Accumulated Depreciation & Amortization for Stoke Therapeutics (STOK) over the last 3 years, with Q4 2024 value amounting to $8.8 million.
- Stoke Therapeutics' Accumulated Depreciation & Amortization rose 3263.38% to $8.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.8 million, marking a year-over-year increase of 3263.38%. This contributed to the annual value of $8.8 million for FY2024, which is 3263.38% up from last year.
- Per Stoke Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $8.8 million for Q4 2024, which was up 3263.38% from $6.7 million recorded in Q4 2023.
- Stoke Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $8.8 million for Q4 2024, and its period low was $4.2 million during Q4 2022.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $6.7 million (2023), whereas its average is $6.6 million.
- As far as peak fluctuations go, Stoke Therapeutics' Accumulated Depreciation & Amortization surged by 5856.91% in 2023, and later soared by 3263.38% in 2024.
- Stoke Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $4.2 million in 2022, then surged by 58.57% to $6.7 million in 2023, then surged by 32.63% to $8.8 million in 2024.
- Its Accumulated Depreciation & Amortization was $8.8 million in Q4 2024, compared to $6.7 million in Q4 2023 and $4.2 million in Q4 2022.